Skip to main content
Review

A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms.

Reeve E, Moriarty F, Nahas R, et al. A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms. Expert Opin Drug Saf. 2017;17(1):39-49. doi:10.1080/14740338.2018.1397625.

Save
Print
November 29, 2017
Reeve E, Moriarty F, Nahas R, et al. Expert Opin Drug Saf. 2017;17(1):39-49.

Deprescribing has been recommended as a way to reduce polypharmacy. This review examines safety concerns associated with deprescribing among older patients and offers strategies to reduce risks. The authors suggest that further research is needed to understand potential harms of deprescribing and highlight the importance of shared decision-making to improve the safety of this process.

Save
Print
Cite
Citation

Reeve E, Moriarty F, Nahas R, et al. A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms. Expert Opin Drug Saf. 2017;17(1):39-49. doi:10.1080/14740338.2018.1397625.

Related Resources